NovoCure (NVCR) Enterprise Value Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | NovoCure | 1.90 Bn | 1.47 Bn | 135.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -32.28% |
| Dec 31, 2025 | 52.58% |
| Sep 30, 2025 | -12.19% |
| Jun 30, 2025 | 45.67% |
| Mar 31, 2025 | -69.25% |
| Dec 31, 2024 | -0.78% |
| Sep 30, 2024 | -0.92% |
| Jun 30, 2024 | 22.41% |
| Mar 31, 2024 | -0.22% |
| Dec 31, 2023 | -2.62% |
| Sep 30, 2023 | -57.59% |
| Jun 30, 2023 | 23.13% |
| Mar 31, 2023 | -0.71% |
| Dec 31, 2022 | -75.48% |
| Sep 30, 2022 | -5.11% |
| Jun 30, 2022 | -49.38% |
| Mar 31, 2022 | 9.27% |
| Dec 31, 2021 | -87.28% |
| Sep 30, 2021 | -60.06% |
| Jun 30, 2021 | -18.09% |
| Mar 31, 2021 | -96.60% |
| Dec 31, 2020 | -118.55% |
| Sep 30, 2020 | -8.06% |
| Jun 30, 2020 | -23.43% |
| Mar 31, 2020 | 1.17% |
| Dec 31, 2019 | 6.52% |
| Sep 30, 2019 | 3.73% |
| Jun 30, 2019 | -12.32% |
| Mar 31, 2019 | -2.86% |
| Dec 31, 2018 | 19.08% |
| Sep 30, 2018 | -18.36% |
| Jun 30, 2018 | -27.15% |
| Mar 31, 2018 | -15.30% |
| Dec 31, 2017 | 7.69% |
| Sep 30, 2017 | -32.62% |